| __timestamp | Arrowhead Pharmaceuticals, Inc. | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 23068000 |
| Thursday, January 1, 2015 | 382000 | 33277000 |
| Friday, January 1, 2016 | 158333 | 184902000 |
| Sunday, January 1, 2017 | 31407709 | 437411000 |
| Monday, January 1, 2018 | 16142321 | 827478000 |
| Tuesday, January 1, 2019 | 168795577 | 934678000 |
| Wednesday, January 1, 2020 | 87992066 | 951266000 |
| Friday, January 1, 2021 | 138287000 | 1382097000 |
| Saturday, January 1, 2022 | 232810000 | 1553153000 |
| Sunday, January 1, 2023 | 240735000 | 1757661000 |
| Monday, January 1, 2024 | 3551000 | 2168701000 |
Unlocking the unknown
In the competitive world of biotechnology, Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc. have charted distinct paths in their financial journeys. From 2014 to 2023, Exelixis has consistently outperformed Arrowhead in gross profit, showcasing a robust growth trajectory. In 2023, Exelixis achieved a gross profit of approximately $1.76 billion, marking a staggering 660% increase from 2014. In contrast, Arrowhead's gross profit peaked at around $240 million in 2023, a significant rise from its modest beginnings in 2014.
Exelixis's financial prowess is evident, with its gross profit in 2023 being over seven times that of Arrowhead. This disparity highlights Exelixis's strategic market positioning and operational efficiency. However, Arrowhead's growth, despite being overshadowed, is commendable, reflecting its potential in the biotech sector. As we look to the future, the missing data for 2024 leaves room for speculation and anticipation.
Gross Profit Comparison: Gilead Sciences, Inc. and Exelixis, Inc. Trends
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Biogen Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Incyte Corporation and Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: Catalent, Inc. vs Exelixis, Inc.
Who Generates Higher Gross Profit? Exelixis, Inc. or Travere Therapeutics, Inc.
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Veracyte, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and MiMedx Group, Inc.